{
    "2021-10-08": [
        [
            {
                "time": "",
                "original_text": "复星医药一年内4次出售资产意图何为？ 资产异常",
                "features": {
                    "keywords": [
                        "复星医药",
                        "出售资产",
                        "意图"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星出售多家子公司股权，回笼超40亿",
                "features": {
                    "keywords": [
                        "复星",
                        "子公司股权",
                        "回笼资金"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "多家知名药企，卖了！",
                "features": {
                    "keywords": [
                        "知名药企",
                        "出售"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药现1笔大宗交易 共成交1,287.50万元",
                "features": {
                    "keywords": [
                        "复星医药",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "再次出售两家子公司股权，复星医药在下一盘什么样的棋？",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司股权",
                        "战略调整"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "复星医药今日大宗交易成交25万股，成交价51.5元溢价0.0%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "大宗交易",
                        "溢价"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "知名药企年内出售四家子公司股权！",
                "features": {
                    "keywords": [
                        "知名药企",
                        "子公司股权",
                        "出售"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药人才招聘（10.08更新）",
                "features": {
                    "keywords": [
                        "医药人才",
                        "招聘"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "美国加大新冠检测，什么信号？境外疫苗有效率大降",
                "features": {
                    "keywords": [
                        "新冠检测",
                        "疫苗有效率",
                        "美国"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药大跌",
                "features": {
                    "keywords": [
                        "复星医药",
                        "大跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药年内出售四公司股权 回笼资金41亿布局新赛道加速转型",
                "features": {
                    "keywords": [
                        "复星医药",
                        "出售股权",
                        "回笼资金",
                        "转型"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药持续梳理体外诊断业务",
                "features": {
                    "keywords": [
                        "复星医药",
                        "体外诊断",
                        "业务梳理"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "快讯 | 复星医药：近16亿元对价转让诊断板块两项资产，推进资产和业务梳理及一体化发展",
                "features": {
                    "keywords": [
                        "复星医药",
                        "诊断板块",
                        "资产转让",
                        "一体化发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}